Game Creek Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.08M Sell
5,070
-1,555
-23% -$1.59M 2.15% 13
2026
Q1
$6.09M Sell
6,625
-125
-2% -$127K 2.03% 13
2025
Q4
$7.25M Sell
6,750
-675
-9% -$645K 2.4% 8
2025
Q3
$5.67M Buy
7,425
+5,125
+223% +$3.81M 1.98% 10
2025
Q2
$1.79M Buy
+2,300
New +$1.79M 0.77% 43
2018
Q1
Sell
-4,400
Closed -$372K 166
2017
Q4
$372K Buy
+4,400
New +$374K 0.1% 152

Other funds holding LLY

Game Creek Capital's LLY Position: Q2 2026 in Review

Game Creek Capital reduced its Eli Lilly (LLY) stake by 23% in Q2 2026, selling an estimated $1.59M and leaving 5,070 shares worth $6.08M. The position accounts for 2.15% of the portfolio, ranked #13.

Game Creek Capital first reported a position in LLY in Q4 2017 and has held it in 6 quarters since. The position peaked at $7.25M in Q4 2025. 4,631 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Game Creek Capital held 5,070 shares of Eli Lilly worth $6.08M as of Q2 2026.
  • Game Creek Capital sold 1,555 Eli Lilly shares in Q2 2026, an estimated $1.59M.
  • Eli Lilly made up 2.15% of Game Creek Capital's portfolio in Q2 2026, its #13 holding.
  • Game Creek Capital first reported a position in Eli Lilly in Q4 2017 and has held it in 6 quarters since.
  • Game Creek Capital's Eli Lilly position peaked at $7.25M in Q4 2025.
  • 4,631 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Game Creek Capital's 13F filing for Q2 2026, filed 13 Aug 2026.